Acanthosis Nigricans
Conditions
Brief summary
evaluate and compare the clinical Efficacy & Safety Of Fractional Carbon Dioxide (Co₂) Laser Plus Topical Metformin In Treatment Of Acanthosis Nigricans.
Detailed description
combining fractional CO₂ laser with topical metformin may provide a synergistic therapeutic effect. This study aims to evaluate and compare the efficacy and safety of fractional CO₂ laser combined with topical metformin versus fractional CO₂ laser using a split-neck design
Interventions
applied to one half of the neck only
Sponsors
Study design
Eligibility
Inclusion criteria
* \- male or female patients aged 18-50 years * clinically \& dermoscopy diagnosed acanthosis nigricans involving the neck * skin types iii-v * stable systemic condition for at least 3 months * willingness to comply with study protocol and follow-up
Exclusion criteria
* \- pregnancy or lactation * malignancy-associated acanthosis nigricans * active skin infection or inflammatory dermatosis at the treatment site * history of keloid or hypertrophic scar formation * photosensitivity disorders * use of topical or systemic treatment for acanthosis nigricans within the last 4 weeks * previous laser treatment to the neck within the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of severity using the acanthosis nigricans area and severity index (ANASI) score at baseline and after completion of treatment | 5-7 days |
Secondary
| Measure | Time frame |
|---|---|
| Physician global assessment (PGA) | 5-7 days |